Campaign Closing and presentation of the excellent results of patients treated with Vilac Plus products in the program Que no Me Pierda with John Arandia, Canal 11 Red ONE, Bolivia. Tuesday May 4, 2010. With the scientific opinion of Dr. Luciano Gutierrez, eminent obstetrician and gynecologist oncologist well known in South America.
News
Interview : Health campain in Bolivia
During the Solidarity campaign against Cancer in Bolivia, excellent results were obtained in the city of La Paz. The population of Santa Cruz is informed on a substantial discount for this department.
QNMP Campain Against Cancer, Intermediate Report November 5th, 2009
Reporte intermedio de la Campaña contra el Cancer cervicouterino y cancer de mama en 10 pacientes. Programa televisivo Que no me Pierda. 5 de noviembre de 2009. Participación externa del Ginecólogo Luciano Gutierrez.
Second Vilac Plus Campain QNMP
The second Vilac Plus campaign against cervical cancer and breast cancer was launched on 13 July 2009.
The campaign is funded by Solayni, Vilac Plus distributor in South America, and supported by the most important television show in Bolivia, QNMP (Que No Me Pierda).
Vilac Plus – QNMP Health Campain Conclusion and Results
The TV show Que No Me Pierda, led by the renowned journalist John Arandia, presents nearly one million people the results of the health campaign sponsored by Vilac Plus and the program.
(more…)
Carlos Ávila about the surprising effets of Vilac Plus over the Dengue
Carlos Avila, biochemist, makes a statement about the surprising results the laboratories achieved on the 19 patients with hemorrhagic fever and dengue, with important leucopenia and thrombocytopenia. (more…)
Spot Dengue
This TV advertisement is the result of the joint effort of four non-profit organizations that fight against this endemic problem.
Press Release
PRESS RELEASE
The Colegio Médico de Beni [Beni Medical Association] and the Germán Busch Municipal Hospital communicate the following information for public release:
- Owing to the health emergency and social demand due to the dengue epidemic in our Department and in the entire country, and in view of the fact that there is no specific treatment to prevent and/or reduce the severity of the symptoms and complications of this disease, an interinstitutional effort was implemented to provide viable alternatives to this complex issue.
- On 5 and 6 February of this year will commence the interinstitutional health conference sponsored by the Colegio Médico del Beni, and among other conclusions, priority is being given to the development of a treatment protocol to perform follow-up on dengue cases at the Germán Busch Municipal Hospital, conscious of the difficult moments experienced by our country with a growing epidemic of dengue and encouraged by the international and also regional experience with treatments including the eubiotic drink VILAC PLUS, considering it to have immunostimulant and excellent antioxidant properties.
- It is with great pleasure that we are reporting to the public the satisfactory results obtained, which have been clinically substantiated and certified in laboratory tests. (more…)
El Deber : Physicians recommend increasing patient defences
EPIDEMIC. Beni doctors suggest use of a Thai product to strengthen the human body
Physicians recommend increasing patient defences
Paura Rodríguez Leyton
Following the successful experience accomplished in the Municipal Hospital Germán Busch of Trinidad, where 19 patients received treatment with Vilac Plus and recorded shorter convalescence than with the standard of care, the Chairman of the Beni Medical Association, Dr Rubén Darío Aukel, and the Director of the abovementioned hospital, Dr Arvi Tordoya Guzmán, recommended the use of the product to counteract the damaging effects of the dengue virus on the human body.
These professionals asserted that administration of the eubiotic drink Vilac Plus as a stimulant to improve the body’s immune defence system is a natural alternative for intervention in the epidemic.
As a result of the trial, the doctors pointed out that when adding this drink into the standard protocol applied against dengue the clinical development of patient cases could be reduced from five days to 24–48 hours.
The product is a food supplement of plant origin that has immunostimulant and antioxidant qualities; clinically, it is suitable to prevent contagious infectious diseases or to reduce their intensity.
Daniel Saint André, General Manager of Solayni, the authorised distributor of the product in Bolivia, assures that the dimensions attained by the epidemic are due not only to factors such as lack of hygiene and health hazards, but that they are fundamentally related to poor diet and the state of malnutrition affecting a high percentage of people in Bolivia. He asserted that prevention is important, as the huge number of people who have contracted dengue in this epidemic are likely to contract another strain of the virus again in the future, and suffer a more powerful version of the disease the next time. He maintained that the population in question, whose unofficial numbers exceed 100,000, were to increase its immune defences, they would be less likely to contract the disease again.
It is suggested that the trial be conducted in further depth by incorporating it in the medical protocols developed for the treatment of dengue.
For Rodrigo Ibáñez, Solayni Sales Manager, the action taken to date against the epidemic would only record temporary results, as the virus is in human beings and the mosquito is only a vector, as initially vectors are born healthy. Both Ibáñez and Saint André asked the health authorities to take the recommendation into account. One litre of the product costs Bs 800, and it is calculated that a person will need to drink one or two litres per year.